Journal of Orthopaedic Translation, 2021 · DOI: https://doi.org/10.1016/j.jot.2021.06.001 · Published: June 9, 2021
Spinal cord injury (SCI) is a severe condition with limited effective treatments, leading to neurological impairments and a significant socioeconomic burden. Recent research indicates that circRNAs are abundant in neural tissues and influence neuronal functions. Following SCI, circRNA expression patterns change significantly, suggesting their involvement in the condition's pathophysiology. This review explores circRNAs' characteristics and regulatory roles in SCI to improve understanding of the disease and promote circRNA-based therapies. Circular RNAs (circRNAs) are a type of non-coding RNA that form closed-loop structures. They are highly abundant, stable, and tissue-specific in the central nervous system (CNS).
Manipulating circRNA expression may offer new therapeutic strategies for SCI.
CircRNAs may serve as promising clinical biomarkers for SCI diagnosis and prognosis.
Exosome-mediated circRNA delivery to injured regions may enhance functional recovery.